NOS1-derived nitric oxide facilitates macrophage uptake of low-density lipoprotein

Journal of Cellular Biochemistry
Anjali RoyMirza S Baig

Abstract

Foam cell formation is a hallmark event during atherosclerosis. The current paradigm is that lipid uptake by a scavenger receptor in macrophages initiates necrosis core formation that characterizes atherosclerosis. We report that NOS1-derived nitric oxide (NO) facilitates low-density lipoprotein (LDL) uptake by macrophages independent of the inflammatory response. LDL uptake could be dramatically suppressed by NOS1 specific inhibitor 1-(2-trifluoromethylphenyl) imidazole (TRIM). Importantly, the notion that NOS1 can mediate uptake of lipoproteins suggests that the foam cell formation is regulated by NOS1-derived NO-mediated mechanism. This is a novel study involving NOS1 as a critical player of foam cell formation and reveals much about the key molecular proteins involved in atherosclerosis. Targeting NOS1 would be a useful strategy in reducing LDL uptake by macrophages and hence dampening the atherosclerosis progression.

References

Dec 1, 1990·The Journal of Clinical Investigation·R L MinorD G Harrison
May 1, 1993·Journal of Cardiovascular Pharmacology·T J VerbeurenS Simonet
Jun 1, 1993·The Journal of Clinical Investigation·Y OharaD G Harrison
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
Apr 17, 1997·Biochemical and Biophysical Research Communications·T Forslund, T Sundqvist
Nov 14, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·K BrandD Neumeier
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·J N WilcoxP A Marsden
Jun 3, 2000·Nitric Oxide : Biology and Chemistry·K K Kopec, R T Carroll
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·C Nathan, M U Shiloh
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P A DetmersE Puré
Nov 4, 2000·The American Journal of Clinical Nutrition·H C Stary
Nov 2, 2002·Nature Medicine·Andrew C Li, Christopher K Glass
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Hirokazu KiriiMitsuru Seishima
Dec 3, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Zheng MaSong Li
Mar 17, 2005·Cardiovascular Research·Lianne S M BoestenBart J M van Vlijmen
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
Apr 22, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Peter J KuhlencordtGeorg Ertl
Jun 17, 2006·Nature Reviews. Immunology·Göran K Hansson, Peter Libby
Nov 5, 2008·Journal of Lipid Research·Linda K Curtiss, Peter S Tobias
Jan 24, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Karin PerssonXi-Ming Yuan
Jan 1, 2008·CSH Protocols·Joachim Weischenfeldt, Bo Porse
Dec 31, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Mireille Ouimet, Yves L Marcel
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Apr 27, 2013·Biochimie·Marcos Raniel StraliottoAndreza Fabro de Bem
Sep 3, 2013·Nature Reviews. Immunology·Kathryn J MooreEdward A Fisher
Oct 2, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yunwei LouYun Zhang
Feb 4, 2014·Human Immunology·Luis Chávez-SánchezFrancisco Blanco-Favela
Jul 8, 2014·Journal of Atherosclerosis and Thrombosis·Xiaolei ZhangJinchuan Yan
Aug 13, 2015·Developmental Neurobiology·Hannah Scheiblich, Gerd Bicker
Sep 2, 2015·The Journal of Experimental Medicine·Mirza Saqib BaigMarcelo G Bonini

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.